Phytochemical Composition of Cranberry (Vaccinium oxycoccos L.) Fruits Growing in Protected Areas of Lithuania
- PMID: 37653891
- PMCID: PMC10223228
- DOI: 10.3390/plants12101974
Phytochemical Composition of Cranberry (Vaccinium oxycoccos L.) Fruits Growing in Protected Areas of Lithuania
Abstract
The fruits of Vaccinium oxycoccos L. are an important source of bioactive compounds with antibacterial, antifungal, and anti-inflammatory effects. Studies on the phytochemical analysis of cranberry fruit samples showed that the qualitative and quantitative composition of biologically active compounds varied in cranberry fruit samples collected from different types of wetland sites: the total anthocyanin content was 698 ± 24-8352 ± 200 µg/g, the total flavonol content-518 ± 16-2811 ± 31 µg/g, the total content of triterpene compounds-4060 ± 122-6542 ± 157 µg/g, the content of chlorogenic acid-17 ± 0.4 µg/g to 1224 ± 41 µg/g, and the total content of proanthocyanidins-919 ± 19 µg EE/g to 3038 ± 137 µg EE/g. The percentage composition of anthocyanins in cranberry fruit varied between the different wetland sites: in some cranberry fruit samples, four anthocyanins (cyanidin-3-galactoside, cyanidin-3-arabinoside, peonidin-3-galactoside, and peonidin-3-arabinoside) were predominant, while in other samples, six anthocyanins (cyanidin-3-galactoside, cyanidin-3-arabinoside, peonidin-3-galactoside, peonidin-3-arabinoside, cyanidin-3-glucoside, and peonidin-3-glucoside) predominated. The results of these studies showed the differences in the composition of secondary metabolites in the studied cranberry samples and prove that the standardization of the qualitative and quantitative composition of cranberry fruit raw materials and the application of routine tests are necessary for the expansion of the use of botanical raw materials in the production of functional foods and phytopreparations.
Keywords: phenolic compounds; raw material; small cranberry; triterpenoids.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Česonienė L., Daubaras R., Paulauskas A., Žukauskienė J., Zych M. Morphological and Genetic Diversity of European Cranberry (Vaccinium oxycoccos L., Ericaceae) Clones in Lithuanian Reserves. Acta Soc. Bot. Pol. 2013;82:211–217. doi: 10.5586/asbp.2013.026. - DOI
-
- Elsayed M., Ahmed A., Ahmed E., Hassan D., Sliem M., Zewail D., Sameh S., Ibrahim Y., Ibrahim A., Ahmed Y., et al. A Review on Bioactive Metabolites and Great Biological Effects of Cranberry. ERU Res. J. 2023;2:177–209. doi: 10.21608/erurj.2023.190174.1009. - DOI
-
- Wang C.-H., Fang C.-C., Chen N.-C., Liu S.S.-H., Yu P.-H., Wu T.-Y., Chen W.-T., Lee C.-C., Chen S.-C. Cranberry-Containing Products for Prevention of Urinary Tract Infections in Susceptible Populations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Arch. Intern. Med. 2012;172:989–996. doi: 10.1001/archinternmed.2012.3004. - DOI - PubMed
LinkOut - more resources
Full Text Sources
